Allente Among World’s First Operators to Integrate Google Common Broadcast Stack, supported by KAON and 3SS
This accomplishment is a milestone achievement which makes Allente one of the world’s first operators to complete Google Common Broadcast Stack integration for an Android TV Operator Tier STB. The project was completed in just six months thanks to close collaboration between Allente, KAONMEDIA, NAGRA, Broadcom, 3SS and Google.
The partnership of 3SS and KAON to deliver Allente’s new service was announced in October 2020. Powerful hybrid KAON BCM72180 PVR STBs will be available to Allente’s over 1 million subscribers, with NAGRA Media CAS, Broadcom 72180 SoC and based on 3SS UX technology, in Q3 2021.
Google created its standardized Common Broadcast Stack (CBS) to accelerate the reach of Android TV OS worldwide. Announced in October 2020, CBS will help more TV viewers to get the next-generation app-rich services they crave. A Broadcast Stack is the software designed for STBs and other TV devices that enables playing and recording of digital TV broadcast signals. Among the positive outcomes of adopting CBS are easier and faster integration for hybrid Android TV OS devices, accelerated time-to-market, simplified upgrades and reduced overall TCO (total cost of ownership). Additionally, with CBS being collectively optimized through Google’s wide-ranging tech partner network, service providers and their subscribers can be even more confident of a superior, next-level Android TV OS viewing experience.
“We congratulate Allente for becoming one of the first operators in the world to leverage the Common Broadcast Stack, and in working closely with world-class technology partners, elevating the digital entertainment user experience for consumers,” commented Matthias Puschmann, Strategic Android TV Partner Development Manager at Google.
The Nordic region’s pre-eminent pay-TV provider, Allente is further building upon its first successful 3SS-enabled project. OnePlace is the satellite and OTT service which Canal Digital launched in February 2018. In 2019 the service was named “Best TV User Experience” in the prestigious CSI Awards. Allente was later formed from the merger of Viasat Consumer and Canal Digital in May 2020, and offers TV via satellite, streaming and other services including IPTV and fibre broadband via open networks to customers in Norway, Sweden, Denmark and Finland.
Allente’s new hybrid KAON BCM72180 PVR STB will give subscribers a range of benefits from high performance to a proven next-gen 3SS-engineered customer experience.
Jon Espen Nergård, Allente CTO, said, “Completion of our STB integration so rapidly is a clear testament to the technology, engineering skill and dedication to customer satisfaction from our partners KAON and 3SS, and indeed those of our wider partnership of collaborators which includes NAGRA, Broadcom and of course Google.”
KAON STB middleware is fully integrated with the Android TV software stack to enable new pre-certified Android TV capabilities such as Custom Over-The-Air Update, among others, further accelerating the introduction of new appealing features.
“We are extremely proud to be the first OEM to complete STB integration on a Broadcom SoC with NAGRA CAS seamlessly integrated with UX delivered by 3SS,” commented Tom Buhl, KAON Media Executive Vice President. “The rapid pace of integration with our highly esteemed partners could hardly be more powerful evidence of the many benefits made possible by the Google Common Broadcast Stack,” he added.
“Our ongoing partnership of trust with Allente is a source of tremendous pride for the entire team at 3SS,” commented Kai-Christian Borchers, Managing Director of 3SS. “In becoming one of the world’s first service providers to embrace Google’s Common Broadcast Stack, Allente is blazing a new trail in innovation and customer focus; we eagerly anticipate helping Allente to deliver leading-edge viewing to consumers in the Nordic region,”
SAFe means speedy integration
This project was accelerated thanks to modern principles of agile development, which were first introduced to Canal Digital by 3SS. At the heart is “SAFe” (Scaled Agile Framework), the practical experience-based software development framework which accelerates and optimizes system deployments.
With SAFe, all stakeholders in a project, both in-house and partners, know the status of objectives and exactly where they are in the progress of a granular roadmap of deliverables. SAFe delivers accelerated, streamlined innovation, better productivity, effective planning and superior products.
Google, Google Play and Android TV are trademarks of Google LLC.
Allente is a leading Nordic TV operator, providing top quality TV and broadband services to over 1 million customers in Norway, Sweden, Denmark and Finland. The company was established in May 2020 by a merger between Canal Digital and Viasat Consumer. In 2020, the two companies had combined net sales of SEK 7 billion. Allente is owned 50/50 by Telenor Group and NENT Group. www.allente.se
KAON is a technology leader in pay-TV and broadband solutions. We ensure the connected home technology which enables consumers to simply change the way they experience entertainment and information within the home with the full line-up of innovative platforms and service solutions to give users easy access to multi-screen experiences anywhere, at any time. KAONMEDIA is well recognized by Tier 1 Operators in more than 90 countries. Headquartered in South Korea, KAONMEDIA has global presence in over 24 countries including Germany, Norway, France, Spain, Netherlands, Australia, USA, Brazil, Mexico, Colombia, Japan, and others. www.kaonmedia.com
About 3 Screen Solutions (3SS)
Since 2009, 3SS has been delivering world-class software solutions to service providers and technology innovators to bring video to any screen. 3SS is an acknowledged leader in system integration, app development, UI/UX design innovation and solution architecture. 3SS designs and engineers front end and back end platforms for major operators and broadcasters worldwide to make customer experiences easier and more personal. 3SS’ customers include major satellite, cable, IPTV, OTT and mobile TV operators, including Swisscom, Com Hem (Tele2), Allente, Proximus, TCC Uruguay, FreeCast (SelectTV), Altibox, ORS (simpliTV), Yes (STINGTV), Vodafone Kabel Deutschland, Stofa, Liberty Global (UPC, Unitymedia), SES, Eutelsat, and O2/Telefonica. Broadcast customers include ProSiebenSat.1, Joyn (ProSiebenSat.1/Discovery), SUPER RTL (TOGGO), n-tv, Blockbuster and Viacom, among others. 3ss.tv, 3ready.tv
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
+82 31 724 8609
+44 20 3514 2525
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)18.9.2021 15:34:00 CEST | Press release
Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS) approved regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19 for the extended use in elderly patients aged 50 years and over, or with at least one underlying medical condition (the obese, cardiovascular disease, chronic lung disease, diabetes, chronic kidney disease, chronic liver disease, and patients with immunosuppressive agents) with mild symptoms of COVID-19, and adult patients with moderate symptoms of COVID-19. This marks the first time a monoclonal antibody treatment for COVID-19 has received a full approval to treat patients with COVID-19 from the Korean MFDS. In February, the Korean MFDS granted a Conditional Marketing Authorisation (CMA) for the emergency use of regdanvimab (CT-P59) and allowed the use of CT-P59 in adult patients aged 60 years and over, or with at least one underlying medical condition (cardiovascular, chronic respiratory disease, diabetes, high blood pressure) w
Ipsen: ESMO 2021: Cabometyx ® Demonstrates Sustained 78% Reduction in Risk of Disease Progression or Death in People Living With Uncommon Form of Thyroid Cancer18.9.2021 06:30:00 CEST | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced presentation of new analyses at the European Society for Medical Oncology (ESMO) Congress 2021 across different forms of cancer for people treated with Cabometyx® (cabozantinib). Of note, the final analysis of the pivotal Phase III COSMIC-311 trial (Abstract LBA67) will be presented, with Cabometyx demonstrating a clinically meaningful, sustained efficacy benefit versus placebo in people living with previously treated radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC). With a median follow-up of 10.1 months, Cabometyx continued to demonstrate superior median progression-free survival (mPFS) with a reduction in the risk of disease progression or death of 78% versus placebo (hazard ratio [HR]: 0.22, 96% confidence interval [CI]: 0.15-0.32; p<0.0001).1 This final analysis is consistent with data from the interim analysis, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2021
Unifrax Hosts Groundbreaking Ceremony for SiFAB™ Manufacturing Line17.9.2021 20:46:00 CEST | Press release
Today, Unifrax, a leading manufacturer of high-performance specialty materials, held a ceremonial event celebrating its first large-scale SiFAB™ Silicon Fiber Anode Battery Technology manufacturing line, which is currently under construction at the company’s north central Indiana facility. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210917005495/en/ Unifrax team celebrates SiFAB groundbreaking at New Carlisle plant. (Photo: Business Wire) The event recognized Unifrax’s ongoing partnership with the State of Indiana and St. Joseph County, along with SiFAB’s continued progress. Unifrax executives, along with the SiFAB manufacturing team and local and state government officials, kicked off the ceremony at 10 a.m. EDT at the New Carlisle, IN plant, with remarks by John Dandolph, president and CEO, Unifrax. “Through the support of the State of Indiana and St. Joseph County, we have the ability to leverage our existing New Carli
Prince William announces 15 Finalists for inaugural year of the £50 million Earthshot Prize17.9.2021 19:01:00 CEST | Press release
The Earthshot Prize announces today its first-ever shortlist of 15 Finalists, each with a chance of winning £1million to support their innovative environmental solutions to the greatest challenges facing the planet. Prince William said: "Over half a century ago, President Kennedy’s ‘Moonshot’ programme united millions of people around the goal of reaching the moon. Inspired by this, The Earthshot Prize aims to mobilise collective action around our unique ability to innovate, problem solve and repair our planet. “I am honoured to introduce the 15 innovators, leaders, and visionaries who are the first ever Finalists for The Earthshot Prize. They are working with the urgency required in this decisive decade for life on Earth and will inspire all of us with their optimism in our ability to rise to the greatest challenges in human history.” Launched by Prince William and The Royal Foundation in October 2020, The Earthshot Prize is the most prestigious global environment prize in history. Li
Wipro Announces Co-innovation Space with Google Cloud17.9.2021 15:32:00 CEST | Press release
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced the launch of the Wipro-Google Cloud Innovation Arena in Bangalore, India. This cloud collaboration space will provide in-house technical expertise, ensure seamless cloud adoption, and accelerate innovation to drive business transformation for customers. By combining the expertise and resources of Wipro FullStride Cloud Services and Google Cloud, this jointly developed innovation center will offer a unique combination of people, processes, and platforms that will collectively create a futuristic experience for customers globally. This state-of-the-art arena will showcase the talent, tools and best practices required to develop and deploy applications on Google Cloud. Jason Eichenholz, Senior Vice President, Global Head of Ecosystems & Partnerships, Wipro Limited said, “We are excited to strengthen our partnership with Google Clou
Zynga Announces ReVamp, the First Multiplayer Social Deception Game For Snapchat17.9.2021 15:00:00 CEST | Press release
Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, announced today that ReVamp, an upcoming multiplayer social deception game, will launch soon in select markets exclusively for Snapchat. The vampire-themed game will be the first social deception title on Snapchat, giving Snapchatters their first chance to sink their teeth into this popular genre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210917005012/en/ Zynga Announces ReVamp, the First Multiplayer Social Deception Game For Snapchat (Graphic: Business Wire) ReVamp is a real-time multiplayer imposter game where players aim to reveal who the vampire player is among their group of friends while they renovate the rooms of an old mansion. In the game, human players must complete renovation tasks, such as demolition and building, to improve their chances of survival while identifying and defeating the vampire during the voting phase. Vampire players mu
BeiGene Receives Positive CHMP Opinion for BRUKINSA ® (Zanubrutinib) for the Treatment of Adults with Waldenström’s Macroglobulinemia17.9.2021 14:00:00 CEST | Press release
BeiGene (NASDAQ: BGNE; HKEX: 06160) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending approval of BRUKINSA (zanubrutinib) for the treatment of adult patients with Waldenström’s macroglobulinemia (WM) who have received at least one prior therapy or first-line treatment for patients unsuitable for chemo-immunotherapy. “Bruton’s tyrosine kinase (BTK) inhibitors have emerged as a promising treatment for WM, yet treatment discontinuation due to lack of response or side effects remains a concern,” said Prof. Christian Buske, Medical Director at the University Hospital Ulm, Germany, and a trial investigator of the ASPEN study. “The ASPEN trial demonstrated that BRUKINSA provided deep and durable responses and offered substantial improvements in safety and tolerability over standard therapy. Patients in Europe with WM may soon have a new treatment option that can offer improved outcomes.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom